Skip to main content

Table 2 Comparison of demographic, clinical and laboratorial data of SSc patients with and without anti-collagen V

From: Anti-collagen type v: a marker of early systemic sclerosis?

 

Positive Anti-collagen V

N = 16

Negative Anti-collagen V

N = 65

p

Disease duration, years (SD)

8.8 (+ 5.1)

14.7 (+ 8.9)

< 0.006

Early-SSc, n (%)

6/16 (38%)

12/65 (18%)

0.17

Rodnan Score, n (SD)

10.9 (+ 12.1)

10.5(+ 12.0)

0.82

Interstitial lung disease, n (%)

6/16 (38%)

43/65 (66%)

0.20

Pulmonary hypertension, n (%)

3/16 (19%)

13/65 (20%)

0.70

Esophageal disease, n (%)

8/16 (50%)

42/65 (65%)

0.80

ANA, n (%)

16/16 (100%)

64/65 (98%)

0.60

Anti-Scl 70, n (%)

5/16 (31%)

17/65 (26%)

0.68

Anticentromere, n (%)

3/16 (18%)

23/65 (35%)

0.24

  1. Values are expressed in n: numbers and percentage (%), or average ± standard deviation (SD). ANA Antinuclear antibodies, Anti-SCl70 anti-topoisomerase I